Catalyst Wire Dossier Catalyst Wire Dossier

CCT301-59 CAR T Therapy

· Shanghai PerHum Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCT301-59 CAR T Therapy, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors [Phase 1]

See pricing